- Physician-scientist honored for contributions in advancing cancer care
Dr. Antoni Ribas was honored with the Award of Excellence in Medicine by the Hope Funds for Cancer Research for his contributions in developing new therapies for malignant melanoma, helping significantly increase the life-expectancy and quality of life for people with this disease.
July 16, 2019 8:00 AMdetail
- Similarities of small cell cancers to blood cancers could lead to better treatments
An interdisciplinary team of UCLA scientists has found that small cell neuroendocrine cancers from a range of tissues have a common molecular signature and share drug sensitivities with blood cancers.
July 08, 2019 8:00 AMdetail
- Simms/Mann UCLA Center for Integrative Oncology named Agency of the Year
The Simms/Mann-UCLA Center for Integrative Oncology has been honored as the social work agency of the year for its collaboration and outstanding work educating students.
July 02, 2019 9:00 AMdetail
- Noninvasive test improves detection of aggressive prostate cancer
A team of researchers from UCLA and the University of Toronto have identified a new biomarker found in urine that can help detect aggressive prostate cancer, potentially saving hundreds of thousands of men each year from undergoing unnecessary surgeries and radiotherapy treatments.
July 01, 2019 8:30 AMdetail
- Professor honored for work in lung cancer research and treatment
Dr. Steven Dubinett has been honored by the American Lung Association for his work on research and treatment of lung cancer.
June 28, 2019 8:00 AMdetail
- Chemical engineer receives major grant for immunotherapy research
Yvonne Chen has received a $1.25 million grant from the Cancer Research Institute to support her studies of immunotherapies for cancer
June 25, 2019 8:00 AMdetail
- Researcher looks for ways to detect deadly cancer before it develops
Dr. Beth Karlan is hopeful that her research will help women get diagnosed with ovarian cancer at an earlier stage
June 24, 2019 7:30 AMdetail
- Study shows more effective method for detecting prostate cancer
A multidisciplinary team of UCLA physicians has found that a new method, which includes biopsy guided by magnetic resonance imaging, or MRI, can be used together with the traditional method to increase the rate of prostate cancer detection.
June 13, 2019 7:00 AMdetail
- UCLA professor’s last gift will support research in cancer and stem cell biology
Shortly before financier and UCLA professor Roy Doumani passed away in March, he and his wife, Carol, contributed $5.25 million to advance research in cancer and stem cell biology at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA.
June 12, 2019 10:00 AMdetail
- Organic chemist named the UC Presidential Chair in Medicinal Chemistry
Michael Jung, UCLA distinguished professor of chemistry and biochemistry, has been named the University of California Presidential Chair in Medicinal Chemistry.
June 11, 2019 9:00 AMdetail
- UCLA Health adopts Microsoft Azure to accelerate medical research and improve patient care
UCLA Health is deploying Microsoft cloud computing services to enable UCLA Health and the David Geffen School of Medicine to synthesize vast amounts of clinical and research data to speed medical discoveries and improve patient care.
June 10, 2019 8:00 AMdetail
- Researchers identify three-drug combination that helps curb the growth of deadly type of skin cancer
A UCLA-led research team has pinpointed a three-drug combination that could prove to be an effective new therapy for people with a specific type of advanced melanoma.
June 06, 2019 8:00 AMdetail
- Researcher receives grant to study cancer screenings for low-income people
Dr. Fola May has received an R03 grant from the National Institutes of Health and the National Cancer Institute.
June 03, 2019 10:30 AMdetail
- Traditional chemotherapy still gold standard over new targeted therapy for HER2-positive breast cancers
Results of a phase 3 clinical trial by researchers at the UCLA Jonsson Comprehensive Cancer Center found that women with HER2-positive breast cancer had significantly better response rates, but more severe side effects, when they were treated with traditional neoadjuvant chemotherapy along with dual HER2-targeted blockade compared to a more novel approach using HER2-targeted chemotherapy plus HER2-targeted blockade.
June 03, 2019 7:45 AMdetail
- Immunotherapy drug improves five-year survival rate of people with advanced lung cancer
In a study led by UCLA investigators, treatment with the immunotherapy drug pembrolizumab helped more than 15 percent of people with advanced non-small cell lung cancer live for at least five years — and 25 percent of patients whose tumor cells had a specific protein lived at least that long.
June 01, 2019 6:00 AMdetail
- Adding ribociclib to hormone therapy extends lives of women with most common metastatic breast cancer
A UCLA-led study has found that using a drug called ribociclib in combination with a common hormone therapy may help premenopausal women with the most common type of breast cancer live longer than if they only receive the hormone therapy.
June 01, 2019 4:30 AMdetail
- Prostate cancer research examines radiation protocol for the whole pelvis
Treating an aggressive disease is always challenging but improving the way therapies are applied can benefit patients by giving them a better outcome.
May 16, 2019 8:00 AMdetail
- Urology professor elected to national association
Dr. Christopher Saigal has been elected to the American Association of Genitourinary Surgeons in recognition of his accomplishments in the field.
May 13, 2019 8:30 AMdetail
- UCLA physician-scientist honored for advancing the field of oncology
Dr. Beth Karlan has been inducted into the 2019 class of Giants of Cancer Care in gynecologic malignancies by OncLive.
May 10, 2019 10:30 AMdetail
- Professor receives grant to study how artificial intelligence could improve cancer diagnosis
Dr. Joann Elmore has been awarded a $375,000 Established Investigator Award from the Melanoma Research Alliance.
May 10, 2019 10:00 AMdetail